Advertisement vbandhakavi, Author at Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

All articles by vbandhakavi 

WuXi XDC opens new GMP facilities in China

With an area of around 7,000m2, the new location features the XBCM2 dual-function facility for bioconjugate drug substance and antibody intermediates production. It also comprises the XDP2 facility,